PERSONALISED MEDICINE FOR NEURODEGENERATIVE DISEASES

Basic Information

With the ageing of the world population, the incidence of neurodegenerative diseases is on the rise. At present, an estimated 47 million people are suffering from Alzheimer’s disease and related disorders, the most prevalent class of neurodegenerative diseases. This figure shows no signs of abating, and is expected to double every 20 years as the population ages. One of the greatest challenges for neurodegenerative diseases treatment is the deciphering of the large variability – in origins, mechanisms and clinical expression – that these debilitating diseases are characterised by. With this in mind, JPND has identified a pressing need for investment aimed at enabling research projects on Personalised Medicine, that may in time bring about the delivery of targeted and timely prevention and therapies for patients of neurodegenerative diseases.

Network JPCOFUND2
Website http://www.neurodegenerationresearch.eu/initiatives/annual-calls-for-proposals/open-calls/personalised-medicine-2019/
Aim of the joint call This call invites proposals for ambitious, innovative, multinational and multidisciplinary collaborative research projects to change the trajectory of these debilitating diseases through the development of Precision Medicine approaches. Relating to the targeting of specific elements responsible for pathology in a given individual at a particular point in time, Precision Medicine is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological/molecular characteristics, along with environmental and lifestyle factors.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 07/01/2019
Deadline Pre-Proposal 12/03/2019 Submitted proposal: n/a
Deadline Full-Proposal 25/06/2019 Submitted proposal: n/a
Evaluation End Date n/a Successful proposal: n/a Proposals funded: n/a
Is call co-funded? Yes
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups n/a
Participating networks

Organisations Participating

Country Organisation
Australia National Health and Medical Research Council (NHMRC)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Canada Canadian Institutes of Health Research (CIHR)
Czech Republic Ministry of Education Youth and Sports (MEYS-MSMT)
Denmark Innovation Fund Denmark (Innofond)
Denmark The Velux Foundations (VELUX)
Finland Academy of Finland (AKA)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Ministry of Education, University and Research (MIUR)
Italy Ministry of Health (MOH/MDS)
Latvia State Education Development Agency (VIAA)
Luxembourg National Fund for Research (FNR)
Netherlands The Netherlands Organisation for Health Research and Development (ZonMw)
Norway Research Council of Norway (RCN)
Poland National Science Centre (NCN)
Portugal Foundation for Science and Technology (FCT)
Portugal Regional Fund for Science and Technology (FRCT)
Romania Ministry of Education, Research and Innovation (MERI)
Slovenia Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
Spain Institute of Health Carlos III (ISCIII)
Sweden Swedish Research Council (VR/SRC)
Turkey The Scientific and Technological Research Council of Turkey (TUBITAK)
United Kingdom Medical Research Council (MRC)
United Kingdom United Kingdom Research and Innovation (UKRI)